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Objectives: Biofilms are associated with persistent infections and resistant to
conventional therapeutic strategies. The aim of this study was to investigate the
quantity of biofilm produced on silicone intranasal splints. Methods: Quantity of
biofilm formation on silicone splints (SS) was tested on 15 strains of Staphylococcus
aureus and Moraxella catarrhalis, respectively. Antimicrobial susceptibility testing
was performed in accordance with European Committee on Antimicrobial Suscepti-
bility Testing recommendations. Results: All tested strains formed different amounts
of biofilm on SS: 66.7% S. aureus and 93.3% M. catarrhalis were weak biofilm
producers and 33.3% S. aureus and 6.7% M. catarrhalis were moderate biofilm
producers. S. aureus formed significantly higher quantity of biofilm compared with
M. catarrhalis (p< 0.05). Multidrug resistant S. aureus produced significantly
higher amount of biofilm compared with non-multidrug resistant strains (p< 0.05).
Conclusion: Quantity of biofilm on SS is highly dependent on bacterial species and
their resistance patterns. Future studies are needed to ascertain another therapeutic
option for prophylaxis prior to SS placement.
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Introduction
Nasal septal surgery, one of the commonest operations performed in
otorhinolaryngological practice, is often followed by nasal packing. There are
no generally accepted standards regarding the materials that should be used for
nasal packing after septoplasty, how long the packing should be left in place, or the
indications for nasal packing [1]. Furthermore, various complications, such as
postoperative infections, were reported to be associated with the use of nasal
packings [2, 3]. Intranasal splints have been used recently as alternatives to
classical nasal packing. The nasal airway splint is designed to provide septal
support and allow nasal breathing postoperatively through the integral airway [4].
Silicone intranasal splints are commercially very popular and have a widespread
use around the world [5]. Splints are typically removed within 4–7 days after
surgery, during which period bacterial nasal residents can colonize splints and
form biofilm [4, 6, 7].
Biofilm is a highly organized multicellular community encased in an
extracellular polymeric matrix that is affixed to a surface. Bacterial populations
within a biofilm, as opposed to their planktonic counterparts, have a reduced
growth rate and a distinct transcriptome. Moreover, they exchange genetic
material at an increased frequency, thereby augmenting their ability to acquire
traits favorable to their persistence [8]. Bacteria in a biofilm have substantially
increased resistance not only to the effectors of innate and acquired immunity, but
also to the action of antibiotics as well [8, 9]. Biofilm is involved in the
pathogenesis of various upper respiratory tract infections that are very difficult
to treat with antibiotics and are often chronic and recurrent in nature [10].
Previously, it was demonstrated that biofilm formation on silicone splints (SS)
increases significantly after 48 h following the placement [6]. However, to the best
of our knowledge, there has been no study investigating the quantity of biofilm
produced on silicone intranasal splints.
Nasal mucosa is a reservoir of many pathogens that inside bacterial biofilm
inhabit mucous membrane. It is generally known that the prevalence of nasal
carriage varies according to the age, geographic area, concomitant respiratory tract
illness, antibiotic consumption, and other factors [11–13]. Staphylococcus aureus
colonizes the nasal mucosa of approximately 30% of the population [14]. Due to
the emergence of resistance to methicillin and other beta-lactam antibiotics in the
early 1960s, and acquisition of other resistance genes during the past several
decades, multiresistant strains of S. aureus have become a serious therapeutic
problem [15]. Besides staphylococci, Moraxella catarrhalis can also reside as a
nasal commensal both in children and adult population [16, 17]. Over the last three
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decades, there has been a dramatic increase in the acquisition of beta-lactam
resistance in M. catarrhalis strains, which implicates high empiric treatment
failures with beta-lactam antibiotics for upper respiratory tract infections [16, 18].
The aim of this study was to determine the quantity of biofilm produced




In the period between May 2014 and December 2014, 15 strains of S. aureus
and M. catarrhalis, respectively, were isolated from nasal swabs of the patients
prior to rhinosurgery at the Clinic of Otorhinolaryngology and Maxillofacial
Surgery, Clinical Centre of Serbia, Belgrade, Serbia. The Clinic represents a
referral centre for otorhinolaryngology diseases in Serbia and a part of the largest
University medical centre. This study was approved by the Institutional Ethical
Committee, and all patients signed the informed consent form prior to their
inclusion in the study.
Identification of the strains was performed in accordance with standard
microbiology procedures and confirmed by automated Vitek2 System (bioMér-
ieux, France). Antimicrobial susceptibility testing (AST) was performed by disk
diffusion method for S. aureus [cefoxitin, ciprofloxacin, clindamycin, fusidic acid,
erythromycin, gentamicin, mupirocin, penicillin, tetracycline, and trimethoprim/
sulfamethoxazole (Bio-Rad, USA)] and M. catarrhalis strains [amoxicillin–
clavulanic acid, erythromycin, nalidixic acid, tetracycline, and trimethoprim/
sulfamethoxazole (Bio-Rad, USA)] in accordance with the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) recommendations [19]. AST
of M. catarrhalis strains to cefuroxime and ceftriaxone was performed by Etest
(bioMérieux, France) and detection of beta-lactamase production by Cefinase test
(bioMérieux, France) [19]. Multidrug resistance was defined as a resistance to
three or more distinct antimicrobial classes.
Biofilm assay
To detect and quantify the production of biofilm, the bacterial suspensions of
grown S. aureus and M. catarrhalis cultures were prepared in sterile saline and
adjusted to the density of 0.5 McFarland standard.
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Preliminary screening of strains’ ability to form biofilm was tested by a
commonly used microtiter plate method in 96-well polystyrene plates (Sarstedt,
USA) [20].
Capacity of biofilm production of 15 strains of S. aureus and M. catar-
rhalis, respectively, was tested on silicone double airway splint I (Websinger,
Wolkersdorf, Austria). SS were cut under aseptic conditions into 1-cm pieces and
placed in separate wells of 24-well microtiter plates (Sarstedt, USA) with 1,800
μL of tryptic soy broth (bioMérieux, France) supplemented with additional 1%
glucose. 200 μL of previously prepared bacterial suspension was added to each
well. Negative control for each plate represented only the medium with and
without SS. After 24 h of incubation at 35 °C in aerobic conditions, plates with
SS were decanted and gently rinsed three times with 2,000 μL of sterile
phosphate-buffered saline (pH 7.2). After air-drying, plates with SS were fixed
with 2,000 μL methanol per well for 20 min, dried, and stained with 2,000 μL of
2% crystal violet per well (bioMérieux, France) for 15 min. Unbounded dye was
rinsed with water. After air-drying, SS were transferred into new 24-well
microtiter plates and dye bound to biofilm formed on SS was released with
2,000 μL of 96% ethanol per well for 20 min at room temperature with gentle
tapping. Extracted dye was transferred to 96-well microtiter plates (150 μL per
well) and optical density (OD) was measured at 570 nm using a microtiter plate
reader (ICN Flow Titertek Multiskan Plus, Germany). The results were calculated
according to Stepanović et al. [20]. Each assay was repeated three times on three
consecutive days. OD value of negative control (SS cultivated in medium without
bacteria) was subtracted from the measured OD values of all tested strains, and
mean OD values from three experiments were calculated. To calculate the
category of biofilm production, the cutoff optical density (ODc) was determined
as three standard deviations above the mean OD of the negative control.
According to the obtained results, all tested strains were divided into four
groups: OD≤ODc – category 0 (no biofilm producer, 0); ODc<OD≤ 2×ODc –
category 1 (weak biofilm producer, +); 2×ODc<OD≤ 4×ODc – category 2
(moderate biofilm producer, ++); and 4×ODc<OD – category 3 (strong biofilm
producer, +++).
Statistical analysis
The data obtained in this study were analyzed in SPSS statistical
program (PASW statistics for Windows, Version 18.0, Chicago: SPSS Inc.,
USA) using methods of descriptive statistics, χ2 test, and Mann–Whitney
U test.
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Results
Susceptibility of analyzed S. aureus and M. catarrhalis strains to antibacte-
rial agents is presented in Table I. Seven (46.7%) strains of S. aureus were
multidrug resistant, while 46.7% strains were resistant only to penicillin and
aminopenicillins. Among the tested M. catarrhalis strains, all (100%) produced
beta-lactamase and were, according to the EUCAST guidelines, resistant to
penicillin and aminopenicillins, 100% of strains showed intermediate susceptibil-
ity to cefuroxime and 20% to trimethoprim–sulfamethoxazole. None of the
M. catarrhalis strains were multidrug resistant.
Preliminary screening revealed that all tested S. aureus and M. catarrhalis
strains possessed the ability to form biofilm (Table I): 20% of M. catarrhalis
strains were weak biofilm producer (category 1, +), 60% of S. aureus strains and
73.3% of M. catarrhalis strains were moderate biofilm producers (category 2,
++), and 40% of S. aureus strains and 6.7% of M. catarrhalis strains were strong
biofilm producers (category 3, +++).
S. aureus and M. catarrhalis strains formed significantly lower amount of
biofilm on SS compared with their initial biofilm formation capacity (p< 0.05)
(Table I): 66.7% of S. aureus strains and 93.3% ofM. catarrhalis strains belonged
to the category of weak biofilm producers, and 33.3% of S. aureus strains and
6.7% of M. catarrhalis strains belonged to the category of moderate biofilm
producers. None of the tested strains of both bacterial species belonged to the
category of strong biofilm producers. S. aureus strains formed significantly higher
quantity of biofilm on SS compared with M. catarrhalis (p< 0.05) (Figure 1a).
Eight strains (53.3%) of S. aureus and eleven strains (73.3%) of
M. catarrhalis that were previously categorized as moderate biofilm producers
reduced the capacity of biofilm production on SS to weak biofilm production. Six
(40%) strains of S. aureus and one (6.7%) strain of M. catarrhalis reduced the
quantity of biofilm formation on SS from category 3 to category 2.
Multidrug resistant S. aureus strains produced significantly higher amount
of biofilm on SS (category 2, ++) compared with non-multidrug resistant strains
(category 1, +) (p< 0.05; Table I, Figure 1b). One (6.7%) S. aureus strain resistant
to penicillin, ampicillin, and tetracycline, and three (20.0%)M. catarrhalis strains
belonging to the same resistotype produced the same amount of biofilm both on
control plate and SS (Table I).
Discussion
Nasal septoplasty procedure may be concluded with nasal packing using SS.
Intranasal splints are widely used after septal surgery for the prevention of
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intranasal adhesions between the nasal septum and lateral nasal wall and to support
the septal position [7]. Although these endonasal materials play an important role
during the postoperative period, they are synthetic and foreign objects in the
human body. As with all medical devices, silicone intranasal splints can be
colonized with bacteria and biofilms could be formed after a short period. Acar
et al. conducted the first comprehensive study on biofilm formation on SS and
presented that 12%, 56%, and 100% of splints exhibited microbial biofilm
formation on their surface at 48, 72, and 96 h after nasal placement, respectively [6].
Table I. Susceptibility pattern and biofilm formation on microtiter plate and silicone intranasal splints of
Staphylococcus aureus and Moraxella catarrhalis strains
Strain S R MP NS
S. aureus 1 A+K, C, G, Cip, E, Cl, T, Fa, M P, A ++ +
S. aureus 2 Cip, T, Fa, M P, A, A+K, C, G, E, Cl +++ ++
S. aureus 3 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 4 A+K, C, G, Cip, Fa, M P, A, E, Cl, T ++ +
S. aureus 5 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 6 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 7 Cip, T, Fa, M P, A, A+K, C, G, E, Cl +++ ++
S. aureus 8 A+K, C, G, Cip, Fa, M P, A, E, Cl, T +++ +
S. aureus 9 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 10 A+K, C, G, Cip, Fa, M P, A, E, Cl, T +++ +
S. aureus 11 A+K, C, Cip, Fa, M P, A, G, E, Cl, T +++ ++
S. aureus 12 A+K, C, G, Cip, E, Cl, Fa, M P, A, T ++ ++
S. aureus 13 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 14 A+K, C, G, Cip, E, C, T, Fa, M P, A ++ +
S. aureus 15 Cip, T, Fa, M P, A, C, G, E, Cl +++ ++
M. catarrhalis 1 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 2 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 3 A+K, Na, E, CTX P, A, CXMa, T+S ++ +
M. catarrhalis 4 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 5 A+K, Na, E, T+S P, A, CXMa ++ +
M. catarrhalis 6 A+K, Na, E, T+S P, A, CXMa ++ +
M. catarrhalis 7 A+K, Na, E P, A, CXMa, CTXa, T+S +++ ++
M. catarrhalis 8 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 9 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 10 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 11 A+K, Na, E, T+S, CTX P, A, CXMa + +
M. catarrhalis 12 A+K, Na, E, T+S, CTX P, A, CXMa + +
M. catarrhalis 13 A+K, Na, E, T+S, CTX P, A, CXMa + +
M. catarrhalis 14 A+K, Na, E, T+S, CTX P, A, CXMa ++ +
M. catarrhalis 15 A+K, Na, E, CTX P, A, CXMa, T+S ++ +
Note: S= susceptible, R= resistant, MP=microtiter plate, NS= nasal splint, P= penicillin, A= ampicillin,
A+K= amoxicillin–clavulanic acid, C= cephalosporin, G= gentamicin, Cip= ciprofloxacin, E= erythro-
mycin, Cl= clindamycin, T= tetracycline, Fa= fusidic acid, M=mupirocin, Na= nalidixic acid, T+S=
trimethoprim–sulfamethoxazole, CXM= cefuroxime, CTX= ceftriaxone.
aIntermediate susceptible.
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Figure 1. Category of biofilm production on silicone intranasal splints. (a) Biofilm production on
silicone intranasal splints by Staphylococcus aureus and Moraxella catarrhalis. (b) Biofilm
production on silicone intranasal splints by multiresistant and non-multiresistant strains of S. aureus.
Results are presented as percent of strains ± standard deviation; 0, no biofilm producer; +, weak
biofilm producer; ++, moderate biofilm producer; and +++, strong biofilm producer
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In their study, visualization of biofilm formation on intranasal splints was
achieved by scanning electron microscopy, using semi-quantitative method for
in vivo determination of biofilm production. Thus, we performed modified in vitro
microtiter plate method on SS and confirmed not only the presence of biofilm on
splints but also its quantities. In this study, all investigated strains of two common
nasal colonizers, S. aureus and M. catarrhalis, had the ability to produce biofilm
on intranasal splints with different capacities (Table I).
Postoperative nasal packing may be performed by various types of packing
materials including Vaseline gauze, bismuth iodoform paraffin paste, Merocel
nasal packs, SS, and others [7, 21]. Dag et al. [5] investigated biofilm formation
capacity of two different nasal materials [Merocel packs (made of polyvinyl
acetal) and SS] and showed that biofilm formation on Merocel is significantly
higher than on SS, mainly due to the different texture and surface properties of
these materials. Similar findings were obtained in the present investigation
showing that both S. aureus and M. catarrhalis strains expressed lower capacity
of biofilm productions on SS compared with polystyrene plastic. Hence, it is of
great importance to choose the most appropriate packing material of known
adhesive capacity for the conclusion of nasal septoplasty, or, in the case of novel
material, to investigate the surface sensitivity for biofilm formation by in vivo and/
or in vitro studies before its introduction in operating theatre. Moreover, these
results indicate the importance of performing quantitative in vitro biofilm investi-
gation on biomaterials, rather than widely used classic quantitative biofilm method
in order to obtain reliable and accurate results [20].
Biofilm is a complex microbial community with multiple species of bacteria
coexisting in a matrix of extracellular polysaccharide substance. Besides the
characteristics of the surface bacteria attach to and the environmental conditions,
the process of biofilm formation is highly dependent on the characteristics of
bacteria that produce biofilm [8]. S. aureus and M. catarrhalis belong to normal
bacterial nasal flora, both in adults and children, with significant difference
between age groups: S. aureus together with coagulase-negative staphylococci
represents predominant flora in adults, whileM. catarrhaliswith S. pneumonia and
Haemophilus influenzae in children population. As common nasal residents, these
pathogens can easily contaminate the surface of silicone intranasal splints and form
biofilm. Accordingly, the capacity of biofilm formation on splints was investigated
with S. aureus andM. catarrhalis nasal colonizer strains in this study. The obtained
results showed significantly greater capacity of S. aureus strains in biofilm
production compared withM. catarrhalis strains. Drago et al. [22] reported similar
findings with S. aureus and M. catarrhalis strains isolated from upper respiratory
tract; however, to the best of our knowledge, this investigation is the first one
examining different capacities of biofilm formation of respiratory pathogens on
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silicone intranasal splints. Our research confirmed that strains of the same species
have different potentials to form biofilm, which implies that biofilm production is
strongly associated with phenotypic and genotypic characteristics of the strains, as
it has recently been reported investigating other medical implants [23].
Common characteristics of S. aureus and M. catarrhalis are the emergence
of resistant and multiresistant strains in the past several decades. Both bacteria
show the capability to produce beta-lactamase or other acquired mechanisms of
resistance [18, 24]. In this study, multiresistant S. aureus strains and M. catar-
rhalis strain resistant to two classes of antibiotics demonstrated a propensity to
form a larger amount of biofilm on intranasal splints compared with other isolates.
This would suggest that the ability to form a superior biofilm structure may be an
important virulence factor in resistant bacterial strains, which is a result of great
importance for future research studies.
The use of antibiotics for surgical procedures is a common practice among
otorhinolaryngologists. A survey carried out among the Members of the US
Rhinology Society showed that 66% of ENT doctors used antibiotics as a routine
practice in postoperative period of septoplasties, and the most common reason for
prophylactic use is the prevention of postoperative infections [25]. Amoxicillin–
clavulanic acid is the most frequently administered antibiotic prior to septoplasty
with nasal packing [5, 6, 21]. Although all strains tested in this study were
sensitive to this drug, microbiology methods typically determine the susceptibility
of planktonic and not sessile form of bacteria (i.e., bacteria in a biofilm). Bacterial
biofilms exhibit a reduced susceptibility and/or resistance to antibiotics [8, 9]. The
penetration of antibiotics into biofilm is significantly reduced, and the bacteria in a
biofilm are exposed to the drug in gradually increasing doses. This gradual
exposure can result in stress-induced metabolic or transcriptional changes in
bacteria and increased resistance to antibiotic therapy [26]. Moreover, in all
previous investigations, prophylactic administration of amoxicillin–clavulanic
acid did not prevent biofilm formation on SS. Another possible treatment for
biofilm is low-dose macrolides. Low-dose clarithromycin therapy has been shown
to alter the structure of biofilms [27].
Further studies are needed to develop methods that block the information
pathway between bacteria and gene transcription, which controls the attachment
and production of biofilms.
Conclusion
Quantity of biofilm formation on silicone intranasal splints is highly
dependent on bacterial species that produce biofilm and also their resistance
INTRANASAL SPLINTS – QUANTIFICATION OF BIOFILM 309
Acta Microbiologica et Immunologica Hungarica 63, 2016
patterns. Further studies are needed to ascertain other therapeutic option for
prophylaxis prior to silicone intranasal splints placement that would inhibit biofilm
formation on biomaterials, and also to identify the factors that affect the formation
and treatment of biofilms.
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